Shaping the future of advanced healthcare

Partner With Us

Empower your patients with access to cutting-edge advancements in modern healthcare. Advanced stem cell therapies offer promising potential to treat and prevent a variety of conditions, including degenerative diseases, musculoskeletal injuries, and age-related frailty.

Get in touch

clinical trials

Access Stem Cell Treatments

Cellcolabs Clinical offers an exclusive opportunity for medical partners to give their patients access to advanced stem cell treatments through our patient-funded clinical trials in the Bahamas. 

These trials are using certified GMP-grade Mesenchymal Stem Cells (MSCs) produced at Cellcolabs’ facility at the Karolinska Institute in Sweden. MSCs hold significant potential across various indications, thanks to their unique ability to support and enhance the body’s natural healing processes.

prevention of cvd

Prevention of Cardiovascular Disease

This clinical trial investigates the potential of MSCs in prevention of cardiovascular disease and follows several longevity and disease biomarkers. This proactive approach to health care seeks to maintain health and prevent development of illness.

This trial is administered through systemic infusion (an IV).

You may be eligible if you:

  • Are aged 25-85
  • Have no known malignant disease
  • Do not fulfil any of our exclusion criteria

mi

Musculoskeletal Injuries

This clinical trial investigates the use of MSCs in addressing musculoskeletal injuries and degeneration, which may arise from accidents, sports injuries, or physical overexertion.

This trial is administered through local injections.

You may be eligible if you are 18 years or older and have:

  • A diagnosed acute or chronic
  • musculoskeletal condition
  • A recent injury that has been adequately treated
  • Recurring symptoms of a previous injury

Clinical trials

  • Prevention of Cardiovascular Disease
  • Musculoskeletal Injuries
  • Approved by local authorities

High Quality MSCs

  • GMP-grade stem cells sourced from bone marrow of healthy, young donors.
  • Manufactured in Cellcolabs’ facility in Stockholm, Sweden.

Safety profile

  • Analysis of 15+ years of MSC research indicates a strong safety profile.
  • Bone marrow-derived MSCs are supported by more published data on safety and efficacy compared to MSCs from other sources.

Widely researched

  • Based on over 20 years of academic research at Karolinska Institute.
  • Over hundreds of clinical trials globally on MSCs.
  • Thousands of patients have received MSC treatment in clinical trials

Collaborate With a Leading Global Partner​

Cellcolabs provides high-quality MSCs sourced from the bone marrow of young, healthy, and voluntary donors, all of whom undergo rigorous pre-screening.

The production and handling of cells adhere to GMP (Good Manufacturing Practices) standards and is based on over 20 years of scientific research at the Karolinska Institute in Sweden.  

Get in Touch
Why cellcolabs?

High-Quality Stem Cells

The manufacturing of cells has been optimised by over 20 years of scientific research at the world-renowned Karolinska Institute and is approved by the Swedish Medical Products Agency. The MSCs used in our trials are manufactured by Cellcolabs’ GMP (Good Manufacturing Practice)-certified environment for iATMP in Stockholm, Sweden.

The clinical trials have received approval by the National Stem Cell Ethics Committee in the Bahamas. 

Safety Profile of MSCs

Mesenchymal Stem Cells (MSCs) derived from bone marrow have been rigorously studied and shown to have a favourable safety profile. A meta-analysis of 62 randomized clinical trials confirmed the safety of MSC treatments compared to placebos, with no serious adverse events reported.

More about our stem cells

A Simple Referral Process

With Cellcolabs Clinical

01 – Pre-Screening

The partner pre-screens patients using Cellcolabs Clinical’s protocols and, if eligible for a trial, refers them to Cellcolabs Clinical via a digital form.

02 – Consultation

Patient gets scheduled for a
consultation with Cellcolabs Clinical’s MD team.

03 – Confirmation

Confirmation of scheduling and booking by Cellcolabs Clinical.

04 – Treatment

Formal inclusion in trial & treatment in the Bahamas (typically one overnight stay).

05 – Follow-Up

Follow-up meetings by partner
providing blood tests, scans and
additional services. Clinical trial is followed up by Cellcolabs Clinical.

Pricing

The treatments are participant-funded, with rates varying based on cell dose and method of administration. 

Prices start from 16.500 USD per treatment.

Questions?

Partner with Cellcolabs to start referring your patients.

Get in touch with nina.leibenfrost@cellcolabs.com to find out more.